CORDIS
EU research results

CORDIS

English EN
Multidisciplinary tools for improving the efficacy of public prevention measures against smoking

Multidisciplinary tools for improving the efficacy of public prevention measures against smoking

Objective

Smoking is the largest avoidable cause of preventable morbidity worldwide. It causes most of the cases of lung cancer and chronic obstructive pulmonary disease (COPD) and contributes to the development of other lung diseases. The control of smoking is considered as a highly important intervention for the prevention of lung diseases. Tobacco consumption is highly influenced by socioeconomic factors. SmokeFreeBrain aims to address the effectiveness of a multi-level variety of interventions aiming at smoking cessation in high risk target groups within High Middle Income Countries (HMIC) such as unemployed young adults, COPD and asthma patients, as well as within the general population in Low Middle Income Countries (LMIC). The project addresses existing approaches aiming to prevent lung diseases caused by tobacco while at the same time it develops new treatments and analyzes their contextual adaptability to the local and global health care system.
SmokeFreeBrain follows an interdisciplinary approach exploiting consortium’s expertise in various relevant fields in order to generate new knowledge. State of the art techniques in toxicology, pulmonary medicine, neuroscience and behavior will be utilized to evaluate the effectiveness of: (i) Public Service Announcement (PSA) against smoking, (ii) the use of electronic cigarettes with and without nicotine as a harm reduction approach and/or cessation aid, (iii) a specifically developed neurofeedback intervention protocol against smoking addiction, (iv) a specifically developed intervention protocol based on behavioral therapy, social media/mobile apps and short text messages (sms) and (v) pharmacologic interventions. The main objective of the project is to evaluate the interventions in terms of health economics, by studying their cost-effectiveness, and proposing a scalable plan and a clear pathway to embedding the proposed interventions into policy and practice both in LMIC as well as in HMIC.

Coordinator

ARISTOTELIO PANEPISTIMIO THESSALONIKIS

Address

Kedea Building, Tritis Septemvriou, Aristotle Univ Campus
54636 Thessaloniki

Greece

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 695 250

Participants (14)

Sort alphabetically

Sort by EU Contribution

Expand all

UNIVERSITY OF SURREY

United Kingdom

Department of Health

United Kingdom

EU Contribution

€ 166 800

AAI SCIENTIFIC CULTURAL SERVICES LIMITED

Cyprus

EU Contribution

€ 345 326

UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA

Italy

EU Contribution

€ 317 050

SERVICIO ANDALUZ DE SALUD

Spain

EU Contribution

€ 245 500

NATIONAL ASSOCIATION OF GENERAL PRACTITIONERS IN BULGARIA

Bulgaria

EU Contribution

€ 121 250

KENTRO NEVROANADRASIS VORIOU ELLADOS EE

Greece

EU Contribution

€ 240 450

HELLENIC OPEN UNIVERSITY

Greece

SALUMEDIA TECNOLOGIAS SL

Spain

EU Contribution

€ 130 625

INSTITUT ZA PLUCNE BOLESTI VOJVODINE

Serbia

EU Contribution

€ 120 200

UNIVERSIDAD DE SEVILLA

Spain

EU Contribution

€ 135 625

ST GEORGE'S HOSPITAL MEDICAL SCHOOL

United Kingdom

EU Contribution

€ 383 500

UNIVERSITY OF PIRAEUS RESEARCH CENTER

Greece

EU Contribution

€ 79 425

TAIPEI MEDICAL UNIVERSITY FOUNDATION*TMU

Taiwan

Project information

Grant agreement ID: 681120

Status

Closed project

  • Start date

    1 November 2015

  • End date

    31 October 2018

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 3 187 865,20

  • EU contribution

    € 2 981 001

Coordinated by:

ARISTOTELIO PANEPISTIMIO THESSALONIKIS

Greece